Torrent Pharma Q3 consolidated net up 8.15% to Rs 83.18 cr

NEW DELHI: Torrent Pharmaceuticals on Monday said its consolidated net profit rose by 8.15 per cent to Rs 83.18 crore for the quarter ended December 31, 2011, vis-a-vis the same period last fiscal, mainly on the back of growth in international revenues.

The company had posted a consolidated net profit of Rs 76.91 crore for the quarter ended December 31, 2010, Torrent Pharmaceuticals said in a filing to the BSE.

Total income of the company stood at Rs 696.59 crore for the quarter ended December 31, 2011, as against Rs 577.53 crore for the quarter ended December 31, 2010, it added.

Torrent Pharma also said its board has declared an interim dividend of Rs 6 per equity share of Rs 5 face value.

"International revenues grew by 33 per cent to Rs 394 crore. Operations in Brazil registered revenue growth of 27 per cent, while Germany-based Heumann registered a revenue growth of 14 per cent," Torrent Pharma said.

Revenues from Torrent Pharma's US operations grew by 67 per cent, while business from Europe (other then Heumann), Russia and CIS countries and the rest of the world recorded a growth of 37 per cent, it added.

The company is present in the cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management areas.

Shares of Torrent Pharmaceuticals closed at Rs 548.15 apiece on the BSE today, down 1.06 per cent from their previous close.